EE+ POEM Archive
For treatment of acute coronary syndrome, prasugrel is better than ticagrelor at preventing recurrent MIs at 1 year
For treatment of acute coronary syndrome, prasugrel is better than ticagrelor at preventing recurrent MIs at 1 year is a topic covered in the EE+ POEM Archive.
To view the entire topic, please log in or purchase a subscription.
Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Barry, Henry, et al., editors. "For Treatment of Acute Coronary Syndrome, Prasugrel Is Better Than Ticagrelor at Preventing Recurrent MIs at 1 Year." EE+ POEM Archive, John Wiley & Sons, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314907/all/For_treatment_of_acute_coronary_syndrome__prasugrel_is_better_than_ticagrelor_at_preventing_recurrent_MIs_at_1_year.
For treatment of acute coronary syndrome, prasugrel is better than ticagrelor at preventing recurrent MIs at 1 year. In: Barry HH, Ebell MHM, Shaughnessy AFA, et al, eds. EE+ POEM Archive. John Wiley & Sons; 2019. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314907/all/For_treatment_of_acute_coronary_syndrome__prasugrel_is_better_than_ticagrelor_at_preventing_recurrent_MIs_at_1_year. Accessed March 23, 2023.
For treatment of acute coronary syndrome, prasugrel is better than ticagrelor at preventing recurrent MIs at 1 year. (2019). In Barry, H., Ebell, M. H., Shaughnessy, A. F., & Slawson, D. C. (Eds.), EE+ POEM Archive. John Wiley & Sons. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314907/all/For_treatment_of_acute_coronary_syndrome__prasugrel_is_better_than_ticagrelor_at_preventing_recurrent_MIs_at_1_year
For Treatment of Acute Coronary Syndrome, Prasugrel Is Better Than Ticagrelor at Preventing Recurrent MIs at 1 Year [Internet]. In: Barry HH, Ebell MHM, Shaughnessy AFA, Slawson DCD, editors. EE+ POEM Archive. John Wiley & Sons; 2019. [cited 2023 March 23]. Available from: https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314907/all/For_treatment_of_acute_coronary_syndrome__prasugrel_is_better_than_ticagrelor_at_preventing_recurrent_MIs_at_1_year.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - For treatment of acute coronary syndrome, prasugrel is better than ticagrelor at preventing recurrent MIs at 1 year
ID - 1314907
ED - Barry,Henry,
ED - Ebell,Mark H,
ED - Shaughnessy,Allen F,
ED - Slawson,David C,
BT - EE+ POEM Archive
UR - https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314907/all/For_treatment_of_acute_coronary_syndrome__prasugrel_is_better_than_ticagrelor_at_preventing_recurrent_MIs_at_1_year
PB - John Wiley & Sons
DB - Evidence Central
DP - Unbound Medicine
ER -
